Mississippi Advocate Sought Boost in Cancer Research Funding
A Mississippi resident traveled to D.C. to push for cancer research funding and legislative support for clinical trials.
Updated on Oct. 7, 2026 in Cancer
Live Poll
Should the federal government increase its annual spending on medical research?
Cancer patient advocate Casey Rinewalt met with Mississippi congressional members in Washington, D.C., to urge support for federal research funding and the Clinical Trial Modernization Act. The effort took place during a national summit aimed at sustaining progress against cancer.
Why it matters
Advocates are working to secure funding that has previously helped drive a 34% drop in cancer mortality over the last three decades. Continued legislative support remains essential for expanding trial access to lower-income patients.
Official reports indicate a 34% decline in cancer mortality rates over the last 30 years. Whether future funding levels will be sufficient to continue this trend remains under investigation.
The players
Casey Rinewalt
A cancer patient advocate who lobbied for increased federal research funding following the death of her mother.
American Cancer Society Cancer Action Network
An organization that advocates for public policies to prevent and treat cancer, hosting an annual summit for patient stakeholders.
The details
The Clinical Trial Modernization Act is designed to remove geographic and financial barriers that often prevent low-income patients from participating in life-saving research. By lobbying for this legislation, advocates hope to ensure that medical trials become more inclusive and representative of all populations affected by cancer.
Timeline
The ACS CAN Leadership Summit and Lobby Day took place in September 2026.
Midterm elections are scheduled to occur in November 2026.
Health Landscape
The push for the Clinical Trial Modernization Act marks a shift toward addressing socioeconomic barriers in medical research. This follows a long-term trend of federal investment that has contributed to significant reductions in cancer-related deaths.
Advocacy for clinical trial reform is relevant for patients who may face geographic or financial barriers to accessing experimental treatments. Discussing trial eligibility with your doctor can help you understand if current or future research participation is a viable option for your care.
The takeaway
Increased research funding has been a cornerstone of the 34% decline in cancer deaths observed over the past 30 years. Patients interested in how research impacts their care should speak with their physician about the potential benefits of participating in clinical trials.
Further reading
Learn more about the latest developments in local advocacy efforts on our Cancer page.
Source note: This article includes information reported by SuperTalk Mississippi Media.
Live Poll
Should the federal government increase its annual spending on medical research?
